Company intelligence / Profile preview

Tus-Holdings

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Tus-Holdings is not itself a drug developer; it is a large, Tsinghua University‑linked holding and science‑park operator that builds and manages industrial clusters (including a "massive health industry platform") and controls/partners with various pharmaceutical, biotech and healthcare companies, but it does not have its own disclosed therapeutic pipeline or clinical-stage drug assets as a standalone entity[2][3][7].

Industry: Investors

Partnerships

Extensive partnerships with universities, research institutions, and governments through its global network of over 300 innovation bases and more than 800 controlled/participating enterprises[3][6].International innovation partnerships via TusPark sites in the UK (Cambridge, Newcastle) to connect UK tech/biotech start‑ups with Chinese markets and funding[6].

Beyond the preview

Go deeper on Tus-Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tus-Holdings.

Explore the full profile